Binder profile
ZINC3873855
Virtual-screening candidate from ZINC.
Bound to: PA2400 — pyoverdine biosynthesis protein PvdJ
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC3873855- UniProt (similar protein)
Q70LM7- Tanimoto
- 0.855
- Target protein
- PA2400
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 425.2
- LogP ≤ 5 -1.64
- H-bond donors ≤ 5 6
- H-bond acceptors ≤ 10 11
- Rotatable bonds ≤ 10 6
- TPSA ≤ 140 Ų 223.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Nc1ncnc2c1ncn2[C@@H]1O[C@@H](CO[P@](=O)(O)CP(=O)(O)O)[C@@H](O)[C@@H]1ONc1ncnc2c1ncn2[C@@H]1O[C@@H](CO[P@](=O)(O)CP(=O)(O)O)[C@@H](O)[C@@H]1O
InChI=1S/C11H17N5O9P2/c12-9-6-10(14-2-13-9)16(3-15-6)11-8(18)7(17)5(25-11)1-24-27(22,23)4-26(19,20)21/h2-3,5,7-8,11,17-18H,1,4H2,(H,22,23)(H2,12,13,14)(H2,19,20,21)/t5-,7+,8-,11+/m0/s1InChI=1S/C11H17N5O9P2/c12-9-6-10(14-2-13-9)16(3-15-6)11-8(18)7(17)5(25-11)1-24-27(22,23)4-26(19,20)21/h2-3,5,7-8,11,17-18H,1,4H2,(H,22,23)(H2,12,13,14)(H2,19,20,21)/t5-,7+,8-,11+/m0/s1
OLCWZBFDIYXLAA-IZCITBFLSA-NOLCWZBFDIYXLAA-IZCITBFLSA-N
Provenance
Annotation context from LigQ_2 search.
- Method
- LigQ nearest_k
- Query
- APC
- Homolog
- Q70LM7
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC3873855 →
- ZINC ZINC20 ZINC3873855 →
- UniProt UniProt Q70LM7 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC3873855”) →
Other binders for this protein
Quick navigation to other ligands bound to PA2400.
PDB 14
Ligands co-crystallized with this protein (structural evidence).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).